Skip to main content

This job has expired

You will need to login before you can apply for a job.

R&D Specialist (Oncolytic Viruses)

Employer
Regeneron Pharmaceuticals, Inc.
Location
Tarrytown, New York, United States of America
Start date
Jul 30, 2021

View more

Job Details

Regeneron is currently seeking a R&D Specialist to join our Infectious Diseases team; in a virology focused technology development group. The individual will work on the development and assessment of novel oncolytic viruses.

As an R&D Specialist, a typical day may include the following:

- Conduct in vivo tumor studies with oncolytic viruses

- Process tissue for RNA based assays (qPCR, RNAseq) and IHC

- Design and analyze qPCR assays

- Perform and troubleshoot in vitro virological assays

- Clone and generate viruses

- Generate cell lines with CRISPR and/or lentivirus transduction

- Maintain and culture cells as necessary

This role may be for you if:

- You are adaptable and have the ability to change tasks as needed

- You enjoy working in a fast-pace environment and have the ability to multi-task and learn new techniques

To be considered for this role, you must have a MS + 2 year of experience or a BS + 5 years of experience. At least a year of experience with animal work is also required. Experience with animal studies, particularly with tumor models. Basic proficiency in molecular biology and cell culture are also required. Preferred to have experience in virology, handling infectious agents, qPCR, cloning, IHC/microscopy, and/or other molecular biology techniques.

Company

Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.
 
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune® which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.

Stock Symbol: REGN

Stock Exchange: NASDAQ

FacebookTwitterInstagramYouTube Logo

Company info
Website
Phone
914-847-7000
Location
Corporate Headquarters
777 Old Saw Mill River Road
Tarrytown
New York
10591
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert